Abstract
This case report discusses a rare, but significant side effect of intravenous cytarabine chemotherapy: corneal epithelial toxicity. A 10-year-old male diagnosed with acute lymphoblastic leukemia (ALL) presented with severe symptoms of corneal epithelial toxicity just 3 days after starting intravenous cytarabine. The patient was successfully treated with a combination of moxifloxacin and dexamethasone eye drops and tear substitutes. The discussion highlights the need for ophthalmic evaluation and prophylactic topical corticosteroids to prevent corneal epithelial toxicity in patients receiving systemic cytarabine. While corneal epithelial toxicity is a benign side effect in a malignant disease, the suffering of an already debilitated patient is significant. This case report emphasizes the importance of understanding the adverse reactions of chemotherapy and the need for preventive measures.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
